Company · CIK 1641640
Nabriva Therapeutics plc
| CIK | 1641640 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L2 |
| Business address | Ireland |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2016-04-28 |
Offerings
6 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-260146 | 2021-10-08 | 2023-10-24 | 3 | |
| 333-248530 | 2020-09-01 | 2022-03-29 | 7 | |
| 333-223739 | 2018-03-16 | 2020-09-01 | 8 | |
| 333-219567 | 2017-07-28 | 2019-06-25 | 6 | |
| 333-214197 | 2016-10-21 | 2016-11-29 | 3 | |
| 333-205073 | 2015-06-18 | 2015-09-21 | 7 |
Filings
36| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-10-24 | EFFECTDeclared effective | 333-260146 | 9999999995-23-003076 |
| 2022-03-29 | 424B5Shelf takedown | 333-248530 | 0001104659-22-039490 |
| 2021-11-01 | EFFECTDeclared effective | 333-260146 | 9999999995-21-004111 |
| 2021-10-08 | S-1Registration filed | 333-260146 | 0001104659-21-124612 |
| 2021-05-06 | 424B5Shelf takedown | 333-248530 | 0001104659-21-062520 |
| 2021-03-01 | 424B5Shelf takedown | 333-248530 | 0001104659-21-030147 |
| 2020-12-11 | 424B5Shelf takedown | 333-248530 | 0001104659-20-134829 |
| 2020-12-10 | 424B5Shelf takedown | 333-248530 | 0001104659-20-134283 |
| 2020-09-11 | EFFECTDeclared effective | 333-248530 | 9999999995-20-002426 |
| 2020-09-01 | S-3Shelf registered | 333-248530 | 0001104659-20-101436 |
| 2020-09-01 | 424B5Shelf takedown | 333-223739 | 0001047469-20-004734 |
| 2020-06-01 | 424B5Shelf takedown | 333-223739 | 0001047469-20-003282 |
| 2020-06-01 | 424B5Shelf takedown | 333-223739 | 0001047469-20-003278 |
| 2019-12-20 | 424B5Shelf takedown | 333-223739 | 0001047469-19-006929 |
| 2019-06-25 | 424B5Shelf takedown | 333-219567 | 0001047469-19-003866 |
| 2018-07-27 | 424B5Shelf takedown | 333-223739 | 0001047469-18-005256 |
| 2018-07-25 | 424B5Shelf takedown | 333-223739 | 0001104659-18-046992 |
| 2018-04-27 | EFFECTDeclared effective | 333-223739 | 9999999995-18-000958 |
| 2018-03-16 | S-3Shelf registered | 333-223739 | 0001104659-18-018344 |
| 2018-03-16 | 424B5Shelf takedown | 333-219567 | 0001047469-18-001775 |
| 2017-09-20 | 424B5Shelf takedown | 333-219567 | 0001047469-17-005985 |
| 2017-09-19 | 424B5Shelf takedown | 333-219567 | 0001047469-17-005934 |
| 2017-08-10 | EFFECTDeclared effective | 333-219567 | 9999999995-17-002091 |
| 2017-07-28 | S-3Shelf registered | 333-219567 | 0001104659-17-047822 |
| 2016-11-29 | 424B5Shelf takedown | 333-214197 | 0001047469-16-016982 |
| 2016-11-09 | EFFECTDeclared effective | 333-214197 | 9999999995-16-006195 |
| 2016-10-21 | F-3Shelf registered | 333-214197 | 0001047469-16-016210 |
| 2015-09-21 | 424B4Final prospectus | 333-205073 | 0001193125-15-324146 |
| 2015-09-17 | EFFECTDeclared effective | 333-206771 | 9999999995-15-002534 |
| 2015-09-17 | EFFECTDeclared effective | 333-205073 | 9999999995-15-002528 |
| 2015-09-17 | F-1/AAmendment | 333-205073 | 0001193125-15-322187 |
| 2015-09-08 | F-1/AAmendment | 333-205073 | 0001193125-15-313499 |
| 2015-08-24 | F-1/AAmendment | 333-205073 | 0001193125-15-300256 |
| 2015-07-07 | F-1/AAmendment | 333-205073 | 0001193125-15-246832 |
| 2015-06-18 | F-1Registration filed | 333-205073 | 0001193125-15-227443 |
| 2015-05-14 | DRSDraft made public | 377-01014 | 0000950123-15-005944 |